Clinical trial / 2010
Rye whole grain and bran intake lowered plasma PSA, insulin, and urinary C-peptide compared with refined wheat in men with prostate cancer.
In a randomized controlled crossover study, 17 men diagnosed with prostate cancer consumed 485 g of rye whole grain and bran products (RP) or refined wheat products with added cellulose (WP) (~50% of daily energy intake). Plasma total PSA concentrations were lower after RP compared with WP, showing a mean treatment effect of -14% (P = 0.04). Fasting plasma insulin and 24-h urinary C-peptide excretion were also lower after RP compared with WP (P < 0.01 and P = 0.01, respectively), while daily excretion of 5 lignans was higher (P < 0.001).
- Study type
- Randomized controlled crossover trial
- Who was studied
- 17 men diagnosed with prostate cancer
- What was measured
- Plasma total PSA, fasting plasma insulin, 24-h urinary C-peptide excretion, urinary lignan excretion
THE PAPER
Rye whole grain and bran intake compared with refined wheat decreases urinary C-peptide, plasma insulin, and prostate specific antigen in men with prostate cancer.
Landberg R, Andersson SO, Zhang JX, Johansson JE, Stenman UH, Adlercreutz H, Kamal-Eldin A, Aman P, Hallmans G. J Nutr, 2010.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.